QUIDELORTHO CORP Share Price Today: Live Updates & Key Insights

QUIDELORTHO CORP share price today is $15.4, up -8.03%. The stock opened at $16.52 against the previous close of $16.57, with an intraday high of $16.52 and low of $15.08.

QUIDELORTHO CORP Share Price Chart

QUIDELORTHO CORP

us-stock
To Invest in {{usstockname}}
us-stock

QUIDELORTHO CORP Share Price Performance

$15.4 -0.0803(-8.03%) QDEL at 23 Mar 2026 02:55 PM Medical Devices
Lowest Today 15.08
Highest Today 16.52
Today’s Open 16.52
Prev. Close 16.57
52 Week High 38.99
52 Week Low 15.08
Day’s Range: Low 15.08 High 16.52
52-Week Range: Low 15.08 High 38.99
1 day return -
1 Week return -13.63
1 month return -27.99
3 month return -48.93
6 month return -46.44
1 year return -58.29
3 year return -82.3
5 year return -89.11
10 year return -

QUIDELORTHO CORP Institutional Holdings

T. Rowe Price Investment Management,Inc. 16.17

BlackRock Inc 15.01

Vanguard Group Inc 11.12

FMR Inc 7.96

iShares Core S&P Small-Cap ETF 6.06

Rubric Capital Management LP 5.55

Invesco Small Cap Value A 4.67

Newtyn Management LLC 4.43

Amvescap Plc. 4.27

Dimensional Fund Advisors, Inc. 4.17

T. Rowe Price US Mid-Cap Growth Equity 4.13

T. Rowe Price Mid-Cap Growth 4.13

State Street Corp 3.92

American Century Companies Inc 3.42

Avantis US Small Cap Value ETF 3.34

Vanguard Total Stock Mkt Idx Inv 3.18

Geode Capital Management, LLC 2.45

Fuller & Thaler Asset Management Inc 2.43

iShares Russell 2000 ETF 2.43

Fidelity Small Cap Value Fund 2.43

Fidelity Value 2.37

T. Rowe Price US Small-Cap Core Equity 2.28

T. Rowe Price Small-Cap Stock 2.28

Vanguard Small Cap Index 2.26

T. Rowe Price Small-Cap Value 2.15

Frontier Capital Management CO Inc 2.12

Segall Bryant & Hamill 1.76

Silvercrest Asset Management Group LLC 1.58

Morgan Stanley - Brokerage Accounts 1.51

Vanguard Small Cap Value Index Inv 1.45

Neuberger Berman Group LLC 1.45

T. Rowe Price U.S. Mid-Cap Gr Eq Tr-D 1.37

The Goldman Sachs Group Inc 1.28

T. Rowe Price U.S. SC Value Eq Tr-D 1.25

Charles Schwab Investment Management Inc 1.25

T. Rowe Price Instl Small-Cap Stock 1.23

Rice Hall James & Associates, LLC 1.22

Vanguard Institutional Extnd Mkt Idx Tr 1.08

DFA US Small Cap Value I 1.06

T. Rowe Price U.S. SC Core Eq Tr-D 1.03

QUIDELORTHO CORP Market Status

Strong Buy: 3

Buy: 2

Hold: 2

Sell: 1

Strong Sell: 0

QUIDELORTHO CORP Fundamentals

Market Cap 1037.57 M

PB Ratio 0.5403

PE Ratio 0.0

Enterprise Value 3701.73 M

Total Assets 5769.30 M

Volume 3485794

QUIDELORTHO CORP Company Financials

Annual Revenue FY25:2730200000 2730.2M, FY24:2782900000 2782.9M, FY23:2993500000 2993.5M, FY22:3266000000 3266.0M, FY21:1698551000 1698.6M

Annual Profit FY25:1274200000 1274.2M, FY24:2579500000 2579.5M, FY23:1283400000 1283.4M, FY22:1936000000 1936.0M, FY21:1270895000 1270.9M

Annual Net worth FY25:-1131800000 -1131.8M, FY24:-2027000000 -2027.0M, FY23:-10100000 -10.1M, FY22:548700000 548.7M, FY21:704226000 704.2M

Quarterly Revenue Q4/2025:723600000 723.6M, Q3/2025:699900000 699.9M, Q2/2025:613900000 613.9M, Q1/2025:692800000 692.8M, Q4/2024:707800000 707.8M

Quarterly Profit Q4/2025:320400000 320.4M, Q3/2025:335600000 335.6M, Q2/2025:274900000 274.9M, Q1/2025:343300000 343.3M, Q4/2024:659900000 659.9M

Quarterly Net worth Q4/2025:-130700000 -130.7M, Q3/2025:-733000000 -733.0M, Q2/2025:-255400000 -255.4M, Q1/2025:-12700000 -12.7M, Q4/2024:-153400000 -153.4M

About QUIDELORTHO CORP & investment objective

Company Information QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.

Organisation Medical Devices

Employees 6500

Industry Medical Devices

CEO Mr. Brian J. Blaser

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

QUIDELORTHO CORP FAQs

What is the share price of QUIDELORTHO CORP today?

The current share price of QUIDELORTHO CORP is $15.4.

Can I buy QUIDELORTHO CORP shares in India?

Yes, Indian investors can buy QUIDELORTHO CORP shares by opening an international trading and demat account with Motilal Oswal.

How to buy QUIDELORTHO CORP shares in India?

You can easily invest in QUIDELORTHO CORP shares from India by:

Can I buy fractional shares of QUIDELORTHO CORP?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of QUIDELORTHO CORP?

QUIDELORTHO CORP has a market cap of $1037.57 M.

In which sector does QUIDELORTHO CORP belong?

QUIDELORTHO CORP operates in the Medical Devices sector.

What documents are required to invest in QUIDELORTHO CORP stocks?

To invest, you typically need:

What is the PE and PB ratio of QUIDELORTHO CORP?

The PE ratio of QUIDELORTHO CORP is N/A and the PB ratio is 0.54.